Highlights

TEZOBELL

Indication :  The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy The treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.   Compositions : Each vial contain Bortezomib 3.5 mg   Storage Condition :  When […]

TEZOBELL Read More »

PEMECINE

Indication :  Malignant Pleural Mesothelioma  PEMECINE® in combination with Cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma.    Non-small cell lung cancer  PEMECINE® in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly

PEMECINE Read More »

TANAXEL

Ovarian carcinoma  First-line therapy in combination with a platinum compound for the treatment of advanced metastatic carcinoma of the ovary.  Second-line therapy for the treatment of advanced metastatic carcinoma of the ovary.   Breast carcinoma  Adjuvant treatment of node-positive breast cancer administered sequentially to standard combination therapy.  Therapy after relapse within 6 months of adjuvant

TANAXEL Read More »

BELOTAXEL

Indication :  Breast cancer  Non-small cell lung cancer  Prostate cancer  Gastric adenocarcinoma  Head and neck cancer  Ovarian cancer    Compositions : Each mL contain Docetaxel trihydrate 21.34 mg ~ Docetaxel 20 mg   Storage Condition : Do not store above 30°C. Store in the original package in order to protect from light. Keep out the

BELOTAXEL Read More »

BELLOXA

Indication :  Oxaliplatin in combination with 5-Fluorouracil (5-FU) and folinic acid (FA) is indicated for: adjuvant treatment of stage III (Duke’s C) colon cancer after complete resection of primary tumor treatment of metastatic colorectal cancer   Compositions : Each mL contain Oxaliplatin 5 mg   Storage Condition :  Store below 30°C, in a hermetic container. 

BELLOXA Read More »

GEMTAN

Indication :  Non-small cell lung cancer Pancreatic cancer Bladder cancer Breast cancer Ovarian cancer  Other therapeutic activity: Gemcitabine alone or in combination has shown activity in advanced breast and ovarian cancer.   Compositions : Each mL contain Gemcitabine hydrochloride 43.27 mg ~ Gemcitabine 38.005 mg   Storage Condition : Store in refrigerator (2 – 8°C).

GEMTAN Read More »

Need More Information?

Contact CKD OTTO Pharma now for more information about our products and services.

Scroll to Top